IBM Stock Drops 4.38% After Anderon Secures CHIPS Act Funding
IBM's stock price dropped by 4.38% on September 16, 2026, closing at $237.49 on the NYSE.
This decline outpaced the Dow Jones Industrial Average, which fell about 1.21%, due to news that IBM's chip unit Anderon secured a major CHIPS Act funding agreement with the U.S. government for a USD 1 billion award to accelerate research and development for a U.S.-based pure-play quantum foundry.
The announcement sparked market reaction, with investors weighing the implications of the funding on IBM's exposure to quantum and advanced semiconductor development.